Common Prostate Cancer Treatment May Be Less Risky Than Thought
Just over a year ago the FDA warned that commonly used hormone-blocking treatments may increase the risk for fatal heart attacks in prostate cancer patients, but a new analysis finds these fears to be unfounded for most men.
Click here to read the full story.
The content has been reported and it will be reviewed by a moderator.
